Chandru Gajendran

Title: Innovations by Inventor Chandru Gajendran

Introduction

Chandru Gajendran, an inventive mind based in Bengaluru, India, has made significant contributions to the field of pharmaceutical sciences. His work focuses on developing innovative compounds that can address critical healthcare challenges, particularly in the realm of neurodegenerative diseases and cancer.

Latest Patents

Gajendran holds a patent for "Cyclopropyl-amide compounds as dual LSD1/HDAC inhibitors." This groundbreaking invention includes novel compounds characterized by their ability to inhibit both LSD and HDAC enzymes. The patent describes various forms of these compounds, encompassing their analogs, tautomeric forms, stereoisomers, and pharmaceutically acceptable salts. These compounds are positioned as potential therapeutic agents for diseases such as malignant tumors, schizophrenia, Alzheimer's disease, and Parkinson's disease, providing hope for innovative treatment options.

Career Highlights

Currently, Chandru Gajendran is associated with Jubilant Epicore LLC, where he contributes his expertise in drug discovery and development. His career reflects a commitment to enhancing healthcare solutions through his inventive spirit and rigorous research.

Collaborations

In his role at Jubilant Epicore LLC, Gajendran collaborates with fellow researchers and innovators, including Sridharan Rajagopal and Mahanandeesha S Hallur. Their collective efforts foster a dynamic environment focused on pushing the boundaries of science and medicine.

Conclusion

Chandru Gajendran exemplifies the spirit of innovation in the pharmaceutical industry, with his patents paving the way for new therapeutic options for serious health conditions. His contributions not only highlight the importance of intellectual property in driving medical advancements but also show the collaborative nature of scientific research in tackling global health issues.